
Assessment of the risk to develop a HIT complication during heparin therapy by the measurement of the global heparin dependent antibodies, whether the isotype is: IgG, IgA or IgM.
Specific measurement of heparin dependent antibodies of the IgG isotype, for the best association with clinical manifestations of HIT and confirmation of this iatrogenic disease.